Canaccord Genuity Group assumed coverage on shares of Omada Health (NASDAQ:OMDA – Free Report) in a report published on Tuesday, MarketBeat.com reports. The firm issued a buy rating and a $27.00 price target on the stock.
Separately, Wall Street Zen raised Omada Health to a “hold” rating in a research note on Monday, June 16th. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, Omada Health has an average rating of “Moderate Buy” and a consensus price target of $23.57.
Check Out Our Latest Research Report on OMDA
Omada Health Price Performance
About Omada Health
Omada’s mission is to bend the curve. Our hope is that, one day, tomorrow’s epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.
Featured Stories
- Five stocks we like better than Omada Health
- Investing In Automotive Stocks
- Rigetti Computing: Cantor’s Bullish Call May Be Just the Start
- What Are Some of the Best Large-Cap Stocks to Buy?
- Big Bank Buybacks: Morgan Stanley, Citi, & Wells Fargo Lead
- 3 REITs to Buy and Hold for the Long Term
- 3 Top Stocks Under $20 Riding the “Made in America” Wave
Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.
